Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
I157602-25mg | 25mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $31.90 | |
I157602-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $105.90 | |
I157602-250mg | 250mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $199.90 | |
I157602-500mg | 500mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $259.90 | |
I157602-1g | 1g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $470.90 | |
I157602-5g | 5g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,399.90 |
Synonyms | Indolelactate | 2-Hydroxy-3-(1H-indol-3-yl)propanoic acid | 3-Indolelactic acid | dl-Indole-3-lactic acid | 3-(Indol-3-yl)lactic acid | alpha-Hydroxy-1H-indole-3-propanoic acid | Indolelactic acid | beta.-Indolyllactic acid |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Product Description | application: DL-Indole-3-lactic Acid is used as a reagent in the synthesis of 2-hydroxy-1-(1H-indol-3-yl)-4-methylpentan-3-one which has weak antibacterial activity against 16 bacterial strains, including Escherichia coli, Bacillus subtilis and Staphylococcus aureus. DL-Indole-3-lactic Acid is also used in the preparation of Monatin, a natural sweet peptidomimetic. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | 2-hydroxy-3-(1H-indol-3-yl)propanoic acid |
---|---|
INCHI | InChI=1S/C11H11NO3/c13-10(11(14)15)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,10,12-13H,5H2,(H,14,15) |
InChi Key | XGILAAMKEQUXLS-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)O |
Isomeric SMILES | C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)O |
Alternate CAS | 832-97-3 |
PubChem CID | 92904 |
Molecular Weight | 205.21 |
Beilstein | 22(1)553 |
Reaxy-Rn | 86202 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
A2403404 | Certificate of Analysis | Dec 19, 2023 | I157602 |
A2403405 | Certificate of Analysis | Dec 19, 2023 | I157602 |
A2403433 | Certificate of Analysis | Dec 19, 2023 | I157602 |
I2402499 | Certificate of Analysis | Dec 19, 2023 | I157602 |
A2403403 | Certificate of Analysis | Dec 19, 2023 | I157602 |
G2219706 | Certificate of Analysis | Jul 25, 2022 | I157602 |
G2219716 | Certificate of Analysis | Jul 25, 2022 | I157602 |
G2219708 | Certificate of Analysis | Jul 25, 2022 | I157602 |
G2219707 | Certificate of Analysis | Jul 25, 2022 | I157602 |
G2219705 | Certificate of Analysis | Jul 25, 2022 | I157602 |
G2219701 | Certificate of Analysis | Jul 25, 2022 | I157602 |
H2321094 | Certificate of Analysis | Jul 11, 2022 | I157602 |
I2222890 | Certificate of Analysis | Jul 11, 2022 | I157602 |
I2222891 | Certificate of Analysis | Jul 11, 2022 | I157602 |
I2222892 | Certificate of Analysis | Jul 11, 2022 | I157602 |
I2222990 | Certificate of Analysis | Jul 11, 2022 | I157602 |
K2301120 | Certificate of Analysis | Jul 11, 2022 | I157602 |
B2224610 | Certificate of Analysis | Jan 03, 2022 | I157602 |
B2224508 | Certificate of Analysis | Jan 03, 2022 | I157602 |
B2224505 | Certificate of Analysis | Jan 03, 2022 | I157602 |
B2224503 | Certificate of Analysis | Jan 03, 2022 | I157602 |
B2224502 | Certificate of Analysis | Jan 03, 2022 | I157602 |
Solubility | DMSO (Slightly), Methanol (Slightly) |
---|---|
Melt Point(°C) | 145.0 to 149.0 °C |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation |
Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P264:Wash hands [and …] thoroughly after handling. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. |
Reaxy-Rn | 86202 |
1. Pan Hu, Xin Yan, Yijia Zeng, Zherui Jiang, Juan Liu, Wu-wen Feng. (2023) An UPLC-MS/MS method for targeted analysis of microbial and host tryptophan metabolism after administration of polysaccharides from Atractylodes macrocephala Koidz. in ulcerative colitis mice. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 235 (115585). [PMID:37523866] |
2. Qixing Nie, Yonggan Sun, Mingzhi Li, Sheng Zuo, Chunhua Chen, Qiongni Lin, Shaoping Nie. (2023) Targeted modification of gut microbiota and related metabolites via dietary fiber. CARBOHYDRATE POLYMERS, 316 (120986). [PMID:37321707] |
3. Qingqing Zhang, Qing Zhao, Tao Li, Longya Lu, Fei Wang, Hong Zhang, Zhi Liu, Huihui Ma, Qihui Zhu, Jingjing Wang, Xuemei Zhang, Yang Pei, Qisha Liu, Yuyu Xu, Jinlong Qie, Xiaoting Luan, Zhibin Hu, Xingyin Liu. (2023) Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8+ T cell immunity. Cell Metabolism, 35 (943-960.e9). [PMID:37192617] |
4. Minzhen Xie, Siqi Gu, Yang Hong, Yan Liu, Xiaohui Rong, Wanying Lu, Heng Liu, Adnan Mohammed Algradi, Anam Naseem, ZunPeng Shu, Qi Wang. (2023) Study on the mechanism of Coptis chinensis Franch. And its main active components in treating Alzheimer's disease based on SCFAs using Orbitrap Fusion Lumos Tribrid MS. JOURNAL OF ETHNOPHARMACOLOGY, 311 (116392). [PMID:37028611] |
5. Zhou Ziyuan, Wang Baohong, Pan Xiaxia, Lv Jiawen, Lou Zhuoqi, Han Yuqiu, Yao Yuanyuan, Chen Jun, Wang Qiangqiang, Li Lanjuan. (2023) Microbial metabolites indole derivatives sensitize mice to D-GalN/LPS induced-acute liver failure via the Tlr2/NF-κB pathway. Frontiers in Microbiology, 13 [PMID:36687651] |
6. Mengmeng Song, Xianjie Sheng, Genyi Ye, Zhuicheng Xu, Xinru Li, Tong Xie, Haishan Deng, An Kang. (2022) Selective enrichment of microbiota-derived tryptophan metabolites in mouse faeces based on molecularly imprinted solid-phase extraction for HPLC analysis. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 212 (114641). [PMID:35182828] |
1. Pan Hu, Xin Yan, Yijia Zeng, Zherui Jiang, Juan Liu, Wu-wen Feng. (2023) An UPLC-MS/MS method for targeted analysis of microbial and host tryptophan metabolism after administration of polysaccharides from Atractylodes macrocephala Koidz. in ulcerative colitis mice. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 235 (115585). [PMID:37523866] |
2. Qixing Nie, Yonggan Sun, Mingzhi Li, Sheng Zuo, Chunhua Chen, Qiongni Lin, Shaoping Nie. (2023) Targeted modification of gut microbiota and related metabolites via dietary fiber. CARBOHYDRATE POLYMERS, 316 (120986). [PMID:37321707] |
3. Qingqing Zhang, Qing Zhao, Tao Li, Longya Lu, Fei Wang, Hong Zhang, Zhi Liu, Huihui Ma, Qihui Zhu, Jingjing Wang, Xuemei Zhang, Yang Pei, Qisha Liu, Yuyu Xu, Jinlong Qie, Xiaoting Luan, Zhibin Hu, Xingyin Liu. (2023) Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8+ T cell immunity. Cell Metabolism, 35 (943-960.e9). [PMID:37192617] |
4. Minzhen Xie, Siqi Gu, Yang Hong, Yan Liu, Xiaohui Rong, Wanying Lu, Heng Liu, Adnan Mohammed Algradi, Anam Naseem, ZunPeng Shu, Qi Wang. (2023) Study on the mechanism of Coptis chinensis Franch. And its main active components in treating Alzheimer's disease based on SCFAs using Orbitrap Fusion Lumos Tribrid MS. JOURNAL OF ETHNOPHARMACOLOGY, 311 (116392). [PMID:37028611] |
5. Zhou Ziyuan, Wang Baohong, Pan Xiaxia, Lv Jiawen, Lou Zhuoqi, Han Yuqiu, Yao Yuanyuan, Chen Jun, Wang Qiangqiang, Li Lanjuan. (2023) Microbial metabolites indole derivatives sensitize mice to D-GalN/LPS induced-acute liver failure via the Tlr2/NF-κB pathway. Frontiers in Microbiology, 13 [PMID:36687651] |
6. Mengmeng Song, Xianjie Sheng, Genyi Ye, Zhuicheng Xu, Xinru Li, Tong Xie, Haishan Deng, An Kang. (2022) Selective enrichment of microbiota-derived tryptophan metabolites in mouse faeces based on molecularly imprinted solid-phase extraction for HPLC analysis. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 212 (114641). [PMID:35182828] |